Award
National Cancer Institute 5R01CA252715-05
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection
Recipient
Not specified
Award Amount
$657,376.00
Ceiling
$657,376.00
Awarded
July 10, 2025
Identifier
5R01CA252715-05
Award for research and development of small-molecule covalent antagonists targeting HPV E6 protein to treat HPV infection, funded by NIH/NCI.
Description
This project involves the development of small-molecule covalent antagonists targeting HPV E6 protein to treat HPV infection. The project is funded by the NIH/NCI and aims to identify drug-like candidates suitable for clinical trials.